江苏省基本药物可获得性实证研究  

Evidence-based Study on the Availability of Essential Drugs in Jiangsu Province

作　　者：徐伟[1] 李静[1] 

机构地区：[1]中国药科大学国际医药商学院,南京211198

出　　处：《中国药房》2013年第8期676-679,共4页China Pharmacy

基　　金：教育部人文社会科学研究规划基金资助项目(No.11YJA790173);江苏省教育厅高校哲学社会科学研究指导项目(No.2012JSD630117)

摘　　要：目的:为促进国家基本药物制度的实施提供参考。方法:采用世界卫生组织(WHO)和国际健康行动欧洲机构的标准药品调查法,对40个基本药物品种在南京、无锡、泰州和盐城的基层和非基层公立医疗卫生机构及零售药店的配备情况进行实地调研,并以此为依据进行江苏省基本药物可获得性实证分析。结果:江苏省基层医疗卫生机构基本药物可获得性略高于非基层医疗卫生机构;公立医疗卫生机构和零售药店基本药物可获得性总体差异不大;相同类型医疗卫生机构内,等效仿制药可获得性高于原研药;不同病种之间基本药物可获得性不同;17种WHO核心目录药品可获得性存在差异。结论:应参考《中国国家处方集》及诊疗规范调整基本药物目录;提高基层医疗卫生机构基本药物配备品种数,推进二、三级医院的国家基本药物制度实施进度;对发病率低的病种应建立基本药物储备方案或快速反应机制。OBJECTIVE： To provide reference for the implementation of national essential drug system. METHODS： Accord- ing to the standard drug methodology of the World Health Organization （WHO） and Health Action International （HAI）, this paper analyzed the availability of essential drugs based on the data collected from both public sectors and retail pharmacies in Nanjing, Wuxi, Taizhou, Yancheng in terms of 40 essential drugs. RESULTS： The availability of essential drugs in primary health care sec- tor was better than in general hospitals, and it showed no gap between public sectors and retail pharmacies. In same type of medi- cal sector, generic equivalent was more available than originator brand; and the availability of essential drugs differed between dis- ease entities; there was difference in the availability of 17 core-list drugs of WHO. CONCLUSION： It is recommended that essen- tial drugs list should be framed and adjusted referring to the National Formulary and the diagnostic and treatment practices; mean- while it＇ s still considerable to increase the types of essential drugs, speed up the pace of national essential drug system in second and third level hospitals and also set up scientific storage system and rapid reaction system for low-incident disease entities.

关 键 词：基本药物 可获得性 实证 江苏 世界卫生组织 标准药品调查法 

分 类 号：R95[医药卫生—药学]